KORU Medical Systems (NASDAQ:KRMD - Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 13th. Analysts expect KORU Medical Systems to post earnings of ($0.03) per share for the quarter. Persons interested in listening to the company's earnings conference call can do so using this link.
KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business had revenue of $8.43 million for the quarter, compared to analyst estimates of $7.52 million. KORU Medical Systems had a negative net margin of 38.16% and a negative return on equity of 20.82%. During the same quarter in the previous year, the firm posted ($0.05) earnings per share. On average, analysts expect KORU Medical Systems to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
KORU Medical Systems Price Performance
Shares of KRMD remained flat at $2.81 during trading hours on Wednesday. 55,132 shares of the stock traded hands, compared to its average volume of 116,228. The company has a market cap of $128.85 million, a P/E ratio of -11.48 and a beta of 0.41. The company has a current ratio of 3.77, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average price of $2.59 and a 200 day moving average price of $2.43. KORU Medical Systems has a 52-week low of $1.98 and a 52-week high of $3.09.
Analyst Ratings Changes
Several equities analysts have recently weighed in on KRMD shares. B. Riley started coverage on shares of KORU Medical Systems in a research note on Thursday, July 25th. They issued a "buy" rating and a $4.00 target price for the company. Piper Sandler lifted their target price on shares of KORU Medical Systems from $2.50 to $3.00 and gave the stock an "overweight" rating in a research note on Thursday, August 8th.
Check Out Our Latest Stock Analysis on KORU Medical Systems
About KORU Medical Systems
(
Get Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
See Also
Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
